Awaken Injectable naturally activates sexual desire by restoring the mind's chemical balance. This on-demand injectable increases arousal for up to 18 hours with Bremelanotide, a libido-inducing and stress-reducing peptide.
Awaken Injectable is an easy-to-administer solution that gives you an instant boost of desire in minutes. The active ingredient, Bremelanotide, is a powerful peptide that works by sending a chemical signal to parts of the brain that naturally trigger passion and sexual desire. Since libidos naturally fluctuate, this on-demand treatment is ideal for both consistent and as-needed support.
Awaken Injectable is a micro-thin, easy-to-use self-injection given just under the skin of the abdomen every 2-4 hours before sexual activity.
Take as needed, meaning you decide the day and time based on your own experience. Effects typically last up to 18 hours.
A self-administered peptide that safely and effectively activates melanocortin receptors, natural substances in the brain that affect mood and thinking. The result is restored chemical balance, increased sexual desire and reduced distress.
Women suffering from low sex drive or other sexual dysfunction.
Bremelonotide is an FDA-approved treatment for women suffering from hypoactive sexual desire disorder (HSDD), which is a common, treatable condition in which women experience ongoing low sexual desire that causes distress for both them and their partners. HSDD affects 1 in 10 premenopausal women in the US and is caused by an imbalance of neurotransmitter activity in the brain.
Because Awaken Injectable is administered with a small needle, those who are uncomfortable self-injecting or having a partner inject should not use this product. Also, women with allergies to injected peptides as well as those with uncontrolled high or low blood pressure (hypertension/hypotension), a history of heart attacks, strokes or unstable angina, plus those who have been instructed by a doctor not to engage in sexual activity should avoid use.
Mild to moderate nausea, redness/flushing, headaches, sinus congestion and itching and redness at the injection site have been reported.